Barclays
WST icon

Barclays’s West Pharmaceutical WST Stock Holding History

Barclays’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9M Hold
50,000
– – ﹤0.01% 1188
2026
Q1 		$12.5M Hold
50,000
– – ﹤0.01% 1329
2025
Q4 		$13.8M Buy
+50,000
New +$13.7M ﹤0.01% 1459
2025
Q1 		– Sell
-215,000
Closed -$70.4M – 5604
2024
Q4 		$70.4M Buy
215,000
+60,900
+40% +$19.2M 0.02% 533
2024
Q3 		$46.3M Buy
+154,100
New +$47.2M 0.01% 700

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Barclays's WST Position: Q2 2026 in Review

Barclays reduced its West Pharmaceutical (WST) stake by 29% in Q2 2026, selling an estimated $31.5M and leaving 246,199 shares worth $88.4M. The position accounts for 0.02% of the portfolio, ranked #537.

Barclays first reported a position in WST in Q2 2013 and has held it in 53 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Barclays held 246,199 shares of West Pharmaceutical worth $88.4M as of Q2 2026.
  • Barclays sold 102,905 West Pharmaceutical shares in Q2 2026, an estimated $31.5M.
  • West Pharmaceutical made up 0.02% of Barclays's portfolio in Q2 2026, its #537 holding.
  • Barclays first reported a position in West Pharmaceutical in Q2 2013 and has held it in 53 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.